Updated: May 8, 2025

Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Franҫois Cornud1, Katelijne de Bie1, Luigi van Riel1
1From the Departments of Radiology (F.C., A.L.) and Urology (M.G.), Clinique de l'Alma, 166 Rue de l'Université, 75007 Paris, France; Department of Urology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands (K.d.B., L.v.R.); and Department of Pathology, i-Path Institut de Pathologie des Hauts-de-France, Amiens, France (P.C.).
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
MRI-guided micro-ultrasound focal laser ablation (FLA) shows promise for localized prostate cancer. Multifiber FLA demonstrated feasibility and safety, with an 18% recurrence rate at 12 months.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: